• 1.

    Siegel RL, et al. Cancer statistics, 2024. CA Cancer J Clin 2024; 74:12494. doi: 10.3322/caac.21820

  • 2.

    Kidney Diseases: Improving Global Outcomes (KDIGO). KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl 2013; 3(1). https://kdigo.org/wp-content/uploads/2017/02/KDIGO_2012_CKD_GL.pdf

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 3.

    Pasternak M, et al. Association of albuminuria and regression of chronic kidney disease in adults with newly diagnosed moderate to severe chronic kidney disease. JAMA Netw Open 2022; 5:e2225821. doi: 10.1001/jamanetworkopen.2022.25821

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 4.

    Hillege HL, et al.; Prevend Study Group. Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity. J Intern Med 2001; 249:519526. doi: 10.1046/j.1365-2796.2001.00833.x

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 5.

    Lee M, et al. Level of albuminuria and risk of stroke: Systematic review and meta-analysis. Cerebrovasc Dis 2010; 30:464469. doi: 10.1159/000317069

  • 6.

    Ahn SY, et al. Dipstick proteinuria and cancer incidence: A nationwide population-based study. J Nephrol 2020; 33:10671077. doi: 10.1007/s40620-020-00740-1

  • 7.

    Tu H, et al. Cancer risk associated with chronic diseases and disease markers: Prospective cohort study. BMJ 2018; 360:k134. doi: 10.1136/bmj.k134

  • 8.

    Luo L, et al. Urinary albumin excretion and cancer risk: The PREVEND cohort study. Nephrol Dial Transplant 2023; 38:27232732. doi: 10.1093/ndt/gfad107

  • 9.

    Luo L, et al. Albuminuria and the risk of cancer: The Stockholm Creatinine Measurements (SCREAM) project. Clin Kidney J 2023; 16:24372446. doi: 10.1093/ckj/sfad145

Can Albuminuria Predict Cancer Risk?

Joana Gameiro Joana Gameiro, MD, PhD, FASN, is an attending nephrologist at the Division of Nephrology and Renal Transplantation, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal. Marco Bonilla, MD, FASN, is an assistant professor of medicine in the Section of Nephrology, Department of Medicine, The University of Chicago, IL.

Search for other papers by Joana Gameiro in
Current site
Google Scholar
PubMed
Close
and
Marco Bonilla Joana Gameiro, MD, PhD, FASN, is an attending nephrologist at the Division of Nephrology and Renal Transplantation, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal. Marco Bonilla, MD, FASN, is an assistant professor of medicine in the Section of Nephrology, Department of Medicine, The University of Chicago, IL.

Search for other papers by Marco Bonilla in
Current site
Google Scholar
PubMed
Close
Restricted access
Save